The outcome of primary tumor resection in the unresectable stage IV colorectal cancer patients who received the bevacizumab-containing chemotherapy

Primary tumor resection (PTR) for unresectable metastatic colorectal cancer (mCRC) patients has been documented to be associated with postoperative hyper-neovascularization and enhanced growth of metastases, which may be prevented by bevacizumab. This study aimed to investigate the survival outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeom, Seung-Seop, Lee, Soo Young, Kwak, Han Deok, Kim, Chang Hyun, Kim, Young Jin, Kim, Hyeong Rok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035101/
https://www.ncbi.nlm.nih.gov/pubmed/32049866
http://dx.doi.org/10.1097/MD.0000000000019258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035101/
https://www.ncbi.nlm.nih.gov/pubmed/32049866
http://dx.doi.org/10.1097/MD.0000000000019258

Ejemplares similares